Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
2
×
deals
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
sickle cell disease
startups
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2
×
adverum biotechnologies
akouos
albert bourla
allergan
alnylam pharmaceuticals
alzheimer's disease
What
acquisitions
2
×
bio
ceo
roundup
albert
announced
biggest
bourla
collabs
company
covid
crispr
daniel
deal
drug
future
gilead
gilead’s
help
imports
introduce
ipo
maker
maps
measured
medicines
month
o’day
patients
pfizer
pfizer’s
plans
revenue
sciences
today
transformative
world’s
years
Language
unknown
unset
Current search:
abbvie
×
acquisitions
×
startups
×
" wisconsin top stories "
×
" cancer immunotherapy "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More